Overview

Dose-Escalation of Botulinum Toxin in Subjects With Osteoarthritis of the Knee

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and tolerability of the drug product at each dose level.
Phase:
Phase 1
Details
Lead Sponsor:
Q-Med AB
Treatments:
Botulinum Toxins